跳至主要内容
临床试验/IRCT20201027049164N6
IRCT20201027049164N6已完成3 期

Investigation of the effect of artemisinin Capsules and Dermaneh (Artemisia persica)and Afsantin)Artemisia absinthium( Capsules in the treatment of coronavirus COVID-19 virus in Afzalipour hospital,kerman, 2020

Kerman University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Patients with signing Informed Consent
  • Age 18-65 years old
  • Positive CRP test for SARS-CoV-2 virus or characteristic signs on a CT scan of the chest with mild to moderate clinical manifestations according to the National Early Warning Score (NEWS) (mild: 1-4 / moderate: 5-6)

排除标准

  • Receipt of any another experimental treatment
  • Severe liver disease
  • Known allergic reaction to drugs
  • Severe renal disease
  • Pregnant or breastfeeding women
  • transfer to the intensive care unit

研究者

相似试验